ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,071Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 51

$623K Total Retail Price of All Prescriptions

Rank: 4 out of 51

428 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 428 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

32% of this provider’s 428 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 10,739 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 759 450 S3 1 1
SIMVASTATIN 746 611 2 3
POTASSIUM CHLORIDE 423 346 3 8
OMEPRAZOLE 389 263 4 7
TRAMADOL HCL 318 197 5 15
FUROSEMIDE 310 239 6 4
METOPROLOL TARTRATE 309 254 7 10
LISINOPRIL 306 242 8 2
ZOLPIDEM TARTRATE 304 189 9 21
METFORMIN HCL 291 196 10 9
MELOXICAM 264 225 11 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 247 118 12 16
ACETAMINOPHEN-CODEINE 237 132 S3 13 28
GLIPIZIDE 216 136 14 33
DICLOFENAC SODIUM 209 118 15 88
ISOSORBIDE MONONITRATE ER 208 179 16 47
WARFARIN SODIUM 200 178 17 19
LEVOTHYROXINE SODIUM 191 169 18 6
AMLODIPINE BESYLATE 188 142 19 5
AMITRIPTYLINE HCL 187 87 R 20 39
HYDROCHLOROTHIAZIDE 170 119 21 14
FLUOXETINE HCL 160 112 22 43
ATORVASTATIN CALCIUM 157 133 23 22
LOSARTAN POTASSIUM 157 131 23 34
TRIAMTERENE-HCTZ 156 119 25 40
METOPROLOL SUCCINATE 155 102 26 23
SPIRIVA 151 129 27 85
CARVEDILOL 147 128 28 29
GABAPENTIN 138 100 29 11
AZITHROMYCIN 135 106 30 25
METOCLOPRAMIDE HCL 131 101 31 99
TAMSULOSIN HCL 125 105 32 37
NEXIUM 117 74 33 20
DIGOXIN 116 115 34 45
ATENOLOL 106 61 35 17
CARISOPRODOL 104 14 R 36 38
METOLAZONE 102 86 37 112
CYCLOBENZAPRINE HCL 101 46 R 38 35
TRAZODONE HCL 99 56 39 32
SULFAMETHOXAZOLE-TRIMETHOPRIM 92 58 40 50
PANTOPRAZOLE SODIUM 88 76 41 66
ALLOPURINOL 86 86 42 24
ROPINIROLE HCL 84 70 43 85
SERTRALINE HCL 79 62 44 27
DILTIAZEM ER 78 68 45 118
CLONIDINE HCL 76 34 46 31
TIZANIDINE HCL 74 27 47 141
PROAIR HFA 74 68 47 44
BENAZEPRIL HCL 73 42 49 95
DICLOFENAC POTASSIUM 70 44 50 171
LOSARTAN-HYDROCHLOROTHIAZIDE 70 57 50 59
KLOR-CON M10 69 49 52 125
BUMETANIDE 66 51 53 150
ADVAIR DISKUS 65 62 54 63
CRESTOR 61 49 55 42
AMIODARONE HCL 61 61 55 187
TERAZOSIN HCL 60 60 57 121
NIASPAN 59 48 58 129
CLOPIDOGREL 58 55 59 30
AGGRENOX 57 57 60 133
CIPROFLOXACIN HCL 56 47 61 26
METHYLPREDNISOLONE 55 35 62 84
VESICARE 55 15 62 204
CITALOPRAM HBR 54 30 64 18
PRISTIQ ER 54 53 64 207
RAMIPRIL 53 30 66 76
INSULIN SYRINGE 53 38 66 64
SPIRONOLACTONE 51 37 68 57
DOXYCYCLINE HYCLATE 50 33 69 60
MECLIZINE HCL 50 36 69 118
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.